GPC
45
-5
SNA
40
-12
CHD
56
3
CMG
44
-9
ADT
64
-7
HPQ
37
-2
BF.B
42
-8
LYB
15
-14
ETN
42
-10
SE
57
-15
HAS
43
-15
ESS
39
-12
FMC
23
-11
EBAY
40
-7
EQIX
50
-5
TRIP
29
-11
HES
54
-14
NVDA
37
-9
WY
34
-11
HUM
27
-2
GPC
45
-5
SNA
40
-12
CHD
56
3
CMG
44
-9
ADT
64
-7
HPQ
37
-2
BF.B
42
-8
LYB
15
-14
ETN
42
-10
SE
57
-15
HAS
43
-15
ESS
39
-12
FMC
23
-11
EBAY
40
-7
EQIX
50
-5
TRIP
29
-11
HES
54
-14
NVDA
37
-9
WY
34
-11
HUM
27
-2
Financhill
Back

Vaxcyte Stock Predictions

The Tariff-Proof Asset in Your Pocket

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
13

PCVX
Vaxcyte

Last Price:
$31.52
Seasonality Move:
12.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Meet the founder that's revolutionizing smartphones

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Vaxcyte Stock Forecast

  • Over the next 52 weeks, Vaxcyte has on average historically risen by 24.9% based on the past 4 years of stock performance.
  • Vaxcyte has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Vaxcyte Stock Undervalued?
    The current Vaxcyte [PCVX] share price is $30.56. The Score for PCVX is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • PCVX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Vaxcyte Stock Go Up Next Year?

  • Over the next 52 weeks, Vaxcyte has on average historically risen by 24.9% based on the past 4 years of stock performance.

Vaxcyte Stock Rating

Sell
13
Vaxcyte (PCVX) is a Sell

Is Vaxcyte overpriced?

  • Vaxcyte has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Vaxcyte Stock Price History

Is PCVX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PCVX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vaxcyte.com

52-Week Data

52-Week High:
121.06
52-Week Low:
30.01

Prediction Charts

Market Cap:
3.9B
Price in USD:
30.56
Volume:
4.3M
Beta:
1.28

Technical Analysis

SMA50:
76.36
SMA100:
83.00
SMA200:
88.21
52-Wk Change:
-53.06%

Stock Predictions

  • Is Vaxcyte stock public?
    Yes, Vaxcyte is a publicly traded company.
  • What is the Vaxcyte stock quote today?
    The Vaxcyte stock price is 30.56 USD today.
  • How to buy Vaxcyte stock online?
    You can buy Vaxcyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-17 74.01 75.23 75.92 73.50
Mar-18 75.04 74.72 75.04 73.32
Mar-19 74.94 76.14 76.38 73.92
Mar-20 75.47 74.46 76.48 73.81
Mar-21 73.66 74.66 76.61 72.78
Mar-24 75.21 73.82 75.33 72.90
Mar-25 73.76 71.90 73.76 71.13
Mar-26 71.53 68.56 72.66 68.39
Mar-27 69.21 70.77 71.53 68.36
Mar-28 70.84 69.46 71.22 68.38
Mar-31 33.07 37.76 37.94 30.12
Apr-1 37.12 32.23 37.92 31.79
Apr-2 32.01 33.69 33.80 30.50
Apr-3 32.64 30.56 33.05 30.01

Vaxcyte Earnings

Vaxcyte Earnings Report: Per Share Vaxcyte Earnings Q1 Q2 Q3 and Q4 last year and next year.

Vaxcyte Forecast Revenue Growth

Vaxcyte Stock Analysis: Historical quarterly revenues per share for Vaxcyte and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.36 per share, and a decrease next year of $0.37 per share.

* Vaxcyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.